Gary Yiu
Principal Scientist at Repertoire Immune Medicines | Cambridge, Massachusetts, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Gary Yiu is an innovative and accomplished scientific leader currently serving as Principal Scientist at Repertoire Immune Medicines, where he leverages over 13 years of R&D experience in the therapeutic and pharmaceutical industries. Trained at Harvard Medical School, Gary has developed a robust expertise in cancer biology, rare diseases, and discovery immunology, positioning him at the forefront of cutting-edge research and development initiatives.
In his current role, Gary leads the Antigen Processing and Presentation team, where he has successfully established advanced cellular platforms for antigen presentation. Under his strategic leadership, the team has generated and validated over 50 specific antigen-presenting cell lines, each engineered to express high levels of single HLA class I or class II proteins. These innovations have been rigorously validated through immunofluorescent staining and flow cytometry analysis, ensuring their utility in translational research and therapeutic applications.
Gary’s proficiency in processes development, mammalian cell culture, and in vitro methodologies has been instrumental in driving key projects forward, fostering internal and external collaborations that enhance the company’s research capabilities. His expertise in ELISA, protein expression, and biotechnology further complements his strategic vision, enabling the team to navigate complex challenges in the field of immunology. With a strong focus on project management and strategic leadership, Gary continues to push the boundaries of scientific discovery, contributing to the development of novel immunotherapies that hold promise for treating cancer and rare diseases.
Principal Scientist at Repertoire Immune Medicines in February 2020 to Present
Principal Scientist at Cogen Immune Medicines in April 2017 to February 2020
Research Scientist III, Discovery Research at Alexion Pharmaceuticals, Inc. in July 2015 to April 2017
Senior Scientist, Molecular Engineering & Cell Biology at Synageva BioPharma Corp. in January 2015 to June 2015
Research Scientist II at Synageva BioPharma Corp. in November 2011 to December 2014
Research Scientist at AstraZeneca R&D Boston in December 2009 to November 2011
Research Scientist at Beth Israel Deaconess Medical Center in January 2003 to January 2009
Instructor at Brigham and Women's Hospital in January 2000 to January 2002
Postdoctoral Research Fellow at Brigham and Women's Hospital in January 1997 to January 2000
See more
See less
HTRF
Cell Line engineering and Development
Protein Engineering
Design of Experiments (DOE)
Product Development
Processes Development
Mammalian Cell Culture
Molecular Biology
Cell
Cell Culture
Cell Biology
Western Blotting
Biomarkers
ELISA
Drug Development
Oncology
Life Sciences
Assay Development
Signal Transduction
Cancer
Biochemistry
PCR
Drug Discovery
Protein Expression
siRNA
In Vitro
Molecular Cloning
Gene Expression
Biopharmaceuticals
Biotechnology
Cell Based Assays
qPCR
Cell-based Assay Development
Rare Diseases
Cancer Research
Flow Cytometry
Cell Signaling
Genetics
Transfection
CRISPR
Immunology
Gene Expression Profiling
Biochemical Assay Development
Fluorescence Microscopy
Translational Research
Validation
Molecular Genetics
Pharmaceutical Industry
R&D
Molecular Immunology
See more
See less
Discover more about Repertoire Immune MedicinesWhat is Gary Yiu email address?
Email Gary Yiu at [email protected]. This email is the most updated Gary Yiu email found in 2026.
What is Gary Yiu phone number?
Gary Yiu phone number is +17815049822 and +17816427818.
How to contact Gary Yiu?
To contact Gary Yiu send an email to [email protected]. If you want to call Gary Yiu try calling on +17815049822 and +17816427818.
What is Gary Yiu net worth?
Gary Yiu has an estimated net worth of $750,000 to $999,999
What company does Gary Yiu work for?
Gary Yiu works for Repertoire Immune Medicines
What is Gary Yiu's role at Repertoire Immune Medicines?
Gary Yiu is Principal Scientist
What industry does Gary Yiu work in?
Gary Yiu works in the Biotechnology Research industry.
Gary Yiu Email Addresses
Gary Yiu Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Gary Yiu
School Principal at Waco ISD
Director Of Pricing & Analytics at Convergint Federal
Owner at Nec Corporation
Sales Development Representative at Check Point Software Technologies, Ltd.
MANAGER, GLOBAL PUCHASING & LOGISTICS at HINDUSTAN GRANITES INC, NEW YORK, USA
Independent Contractor at DRS Talent and People Ops
PRANIC HEALER INSTRUCTOR / LICENSED MASSAGE THERAPIST/ BUSINESS OWNER at MIDWESTPRANICHEALING
Co-teacher ELA and Social Skills at Longview School District
Co-Founder & Lead Designer at PolyGone
Director of Business Development at FJ Turbine Power
Attorney at The Angela G. Katt Law Firm, LLC
EA to CEO at Code Biotherapeutics
Safety and Q.A. Manager at McLane Company, Inc.
Chief Executive Officer at Peacock Property Solutions
Director of Strategic Initiative and Communications at Florida International University - College of Engineering & Computing
Recruiter at USR SYSTEMS LLC
Manager at Logistic Group LLC
Director, Ancillary Services at AvalonBay Communities
Principal Technical Consultant at Medtronic
Financial Controller at Phinney Industrial Roofing
Graduate Assistant at Office of Graduate Studies at UTSA
Software Engineer at Change Healthcare
Principal Sales Representative at Medtronic
Show more
Show less